Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07532564 · ClinicalTrials.gov registry record
Risk Factors, Costs, and Impacts of ED Boarding
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 30,486
- Enrollment target
NCT07532564: Completed study, sponsored by University of Maryland, Baltimore.
NCT07532564 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 30,486 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07532564 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 30,486 participants
- Enrollment target
Study Summary
The goal of this observational study is to learn about the risk factors, costs, and operational impacts of emergency department boarding (patients admitted to the hospital but remaining in the emergency department awaiting placement on an inpatient floor) The main questions it aims to answer is: 1. What characteristics of patients make them more likely to experience ED boarding? 2. What is the impact of ED boarding on costs of health care? 3. How do high-boarding environments affect the clinical care of all patients in the emergency department, including those that do not board themselves. Data will be secondary in nature, collected in the regular Participants already taking intervention A as part of their regular medical care for RA will answer online survey questions about their joint pain for 5 years.
Primary Outcome
Time between admission order placement and ED departure. Only patients admitted to services that routinely take primary care responsibility for boarding patients in the ED will be classified as boarders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,486 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2025-12-31 |
What the finished NCT07532564 record still lists
NCT07532564 is an observational study that tracks outcomes without assigning an intervention. Its 30,486 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT07532564 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07532564 about?
NCT07532564 is a clinical study titled "Risk Factors, Costs, and Impacts of ED Boarding". The goal of this observational study is to learn about the risk factors, costs, and operational impacts of emergency department boarding (patients admitted to the hospital but remaining in the emergency department awaiting placement on an inpatient floor) The main questions it aims to answer is: 1...
What is the current status of trial NCT07532564?
This trial is currently completed. The enrollment target is 30,486 participants. The study started on 2022-01-01. Estimated completion is 2025-12-31.
Who is sponsoring clinical trial NCT07532564?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- NCT04834869 · 30,000 participants
COVID-19 Vaccines Safety Tracking (CoVaST)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI